A glimmer of new hope for SMA patients: Hong Kong Chief personally pledges to secure access to life-saving drug

Following a heartfelt letter and petition by a spinal muscular atrophy (SMA) patient—with hope for the government to accelerate the introduction of FDA-approved drug, Spinraza—Hong Kong Chief Executive Carrie Lam has personally pledged to secure treatment for the rare disease sufferers in Hong Kong, as soon as possible.